These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 10752558)

  • 41. Conformational and dynamical basis for cross-reactivity observed between anti HIV-1 protease antibody with protease and an epitope peptide from it.
    Badaya A; Sasidhar YU
    Int J Biol Macromol; 2018 Oct; 118(Pt B):1696-1707. PubMed ID: 29990556
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Purification and biochemical characterization of recombinant simian immunodeficiency virus protease and comparison to human immunodeficiency virus type 1 protease.
    Grant SK; Deckman IC; Minnich MD; Culp J; Franklin S; Dreyer GB; Tomaszek TA; Debouck C; Meek TD
    Biochemistry; 1991 Aug; 30(34):8424-34. PubMed ID: 1883829
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cross-reactivity of anti-HIV-1-p17-derivative peptide (P30-52) antibody to Env V3 peptide.
    Ota A; Tanaka-Taya K; Ueda S
    Hybridoma; 1999 Apr; 18(2):149-57. PubMed ID: 10380014
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Expression and immunogenicity of sequence-modified human immunodeficiency virus type 1 subtype B pol and gagpol DNA vaccines.
    zur Megede J; Otten GR; Doe B; Liu H; Leung L; Ulmer JB; Donnelly JJ; Barnett SW
    J Virol; 2003 Jun; 77(11):6197-207. PubMed ID: 12743276
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Proteolytic activity of human immunodeficiency virus Vpr- and Vpx-protease fusion proteins.
    Wu X; Liu H; Xiao H; Kappes JC
    Virology; 1996 May; 219(1):307-13. PubMed ID: 8623547
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Enhancement of cellular and humoral immune responses to human immunodeficiency virus type 1 Gag and Pol by a G/P-92 fusion protein expressing highly immunogenic Gag p17/p24 and Pol p51 antigens.
    Kmieciak D; Bolesta E; Naito T; Gzyl J; Kaneko Y; Kozbor D
    J Hum Virol; 2001; 4(6):306-16. PubMed ID: 12082397
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of invariant Thr80 in human immunodeficiency virus type 1 protease structure, function, and viral infectivity.
    Foulkes JE; Prabu-Jeyabalan M; Cooper D; Henderson GJ; Harris J; Swanstrom R; Schiffer CA
    J Virol; 2006 Jul; 80(14):6906-16. PubMed ID: 16809296
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Induction of T-cell immunity to antiretroviral drug-resistant human immunodeficiency virus type 1.
    Stratov I; Dale CJ; Chea S; McCluskey J; Kent SJ
    J Virol; 2005 Jun; 79(12):7728-37. PubMed ID: 15919925
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Naturally occurring amino acid polymorphisms in human immunodeficiency virus type 1 (HIV-1) Gag p7(NC) and the C-cleavage site impact Gag-Pol processing by HIV-1 protease.
    Goodenow MM; Bloom G; Rose SL; Pomeroy SM; O'Brien PO; Perez EE; Sleasman JW; Dunn BM
    Virology; 2002 Jan; 292(1):137-49. PubMed ID: 11878916
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Potent inhibition of drug-resistant HIV protease variants by monoclonal antibodies.
    Bartonová V; Král V; Sieglová I; Brynda J; Fábry M; Horejsí M; Kozísek M; Sasková KG; Konvalinka J; Sedlácek J; Rezácová P
    Antiviral Res; 2008 Jun; 78(3):275-7. PubMed ID: 18329737
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Screening HIV-1 antigenic peptides as receptors for antibodies and CD4 in allosteric nanosensors.
    Ferraz RM; Rodríguez-Carmona E; Ferrer-Miralles N; Meyerhans A; Villaverde A
    J Mol Recognit; 2009; 22(3):255-60. PubMed ID: 19177495
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A new capture test using conjugated peptides for the detection of HIV antibodies.
    Richalet-Sécordel PM; Van Regenmortel MH
    FEMS Microbiol Immunol; 1991 Dec; 4(1):57-64. PubMed ID: 1815712
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Conformations of the HIV-1 protease: A crystal structure data set analysis.
    Palese LL
    Biochim Biophys Acta Proteins Proteom; 2017 Nov; 1865(11 Pt A):1416-1422. PubMed ID: 28846854
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Structural studies on molecular mechanisms of Nelfinavir resistance caused by non-active site mutation V77I in HIV-1 protease.
    Gupta A; Jamal S; Goyal S; Jain R; Wahi D; Grover A
    BMC Bioinformatics; 2015; 16 Suppl 19(Suppl 19):S10. PubMed ID: 26695135
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Polymorphism of HIV type 1 gag p7/p1 and p1/p6 cleavage sites: clinical significance and implications for resistance to protease inhibitors.
    Bally F; Martinez R; Peters S; Sudre P; Telenti A
    AIDS Res Hum Retroviruses; 2000 Sep; 16(13):1209-13. PubMed ID: 10957718
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Differences in human immunodeficiency virus type 1 (HIV-1) anti-p24 reactivities in serum of HIV-1-infected and uninfected subjects: analysis of indeterminate western blot reactions.
    Povolotsky J; Gold JW; Chein N; Baron P; Armstrong D
    J Infect Dis; 1991 Feb; 163(2):247-51. PubMed ID: 1899100
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An antigenic HIV-1 peptide sequence engineered into the surface structure of transferrin does not elicit an antibody response.
    Ali SA; Joao HC; Hammerschmid F; Eder J; Steinkasserer A
    FEBS Lett; 1999 Oct; 459(2):230-2. PubMed ID: 10518025
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification of regions of HIV-1 p24 reactive with sera which give "indeterminate" results in electrophoretic immunoblots with the help of long synthetic peptides.
    Blomberg J; Vincic E; Jönsson C; Medstrand P; Pipkorn R
    AIDS Res Hum Retroviruses; 1990 Dec; 6(12):1363-72. PubMed ID: 2127683
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Epitope specificity, antibody-dependent cellular cytotoxicity, and neutralizing activity of antibodies to human immunodeficiency virus type 1 in autoimmune MRL/lpr mice.
    Lombardi V; Placido R; Scarlatti G; Romiti ML; Mattei M; Mariani F; Poccia F; Rossi P; Colizzi V
    J Infect Dis; 1993 Jun; 167(6):1267-73. PubMed ID: 7684755
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Altered gag polyprotein cleavage specificity of feline immunodeficiency virus/human immunodeficiency virus mutant proteases as demonstrated in a cell-based expression system.
    Lin YC; Brik A; de Parseval A; Tam K; Torbett BE; Wong CH; Elder JH
    J Virol; 2006 Aug; 80(16):7832-43. PubMed ID: 16873240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.